How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Whole Blood Transfusion Filters Market
- By Filter Type: Leukocyte Reduction Filters, Microaggregate Filters, Blood Transfusion Set Filters, Debris Filters, Platelet Filters
- By Application: Red Blood Cell Transfusion, Platelet Transfusion, Plasma Transfusion, Whole Blood Transfusion
- By End User: Hospitals, Blood Banks, Diagnostic Laboratories, Ambulatory Surgical Centers
- By Material: Polypropylene, Polyethylene, Polycarbonate, Polyvinyl Chloride (PVC)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Leukocyte Reduction Filters leads By Filter Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.164 →
- 11 Company Profiles 17 players: SWOT & benchmarking p.172 →
Full report · locked preview
Everything inside the Whole Blood Transfusion Filters Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Filter Type 5
Application 4
End User 4
Material 4
Companies profiled
Terumo Corporation
Fresenius Kabi
Haemonetics Corporation
Baxter International Inc.
Macopharma
Nipro Corporation
Sartorius AG
Grifols
S.A.
B. Braun Melsungen AG
Asahi Kasei Medical Co. Ltd.
Miltenyi Biotec
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Fresenius Kabi
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Haemonetics Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Macopharma
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Grifols
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →S.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Asahi Kasei Medical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Miltenyi Biotec
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Pall Corporation (a division of Danaher Corporation)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Becton
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Dickinson and Company (BD)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Ningbo David Medical Device Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →JMS Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,248M by 2033 · 5.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Leukocyte Reduction Filters35.1
- Microaggregate Filters13.6
- Blood Transfusion Set Filters13.6
- Debris Filters18.9
- Platelet Filters18.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$501.9M → $824.1M · 6.4%
Europe$349.8M → $469.7M · 3.8%
Asia Pacific$319.4M → $428.5M · 3.7%
Latin America$197.7M → $281.1M · 4.5%
Middle East and Africa$152.1M → $253.6M · 6.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.952026
4.962027
4.982028
4.992029
5.002030
5.012031
5.032032
5.032033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Terumo Corporation16.0
- Fresenius Kabi19.4
- Haemonetics Corporation6.1
- Baxter International Inc.6.5
- Macopharma11.2
- Nipro Corporation12.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Filter Type19.8%
Application24.1%
End User29.0%
Material27.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America36.5
- Europe20.8
- Asia Pacific19.0
- Latin America12.5
- Middle East and Africa11.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Terumo Corporation | 82 | 79 | 81 | 89 | 75 | 93 | 83 |
| Fresenius Kabi | 75 | 72 | 77 | 70 | 91 | 77 | 77 |
| Haemonetics Corporation | 67 | 78 | 75 | 72 | 74 | 75 | 74 |
| Baxter International Inc. | 62 | 77 | 74 | 71 | 68 | 78 | 72 |
| Macopharma | 66 | 70 | 67 | 70 | 73 | 54 | 67 |
| Nipro Corporation | 48 | 71 | 66 | 48 | 64 | 61 | 60 |
| Sartorius AG | 49 | 47 | 61 | 45 | 46 | 41 | 48 |
| Grifols | 39 | 51 | 45 | 47 | 54 | 40 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Terumo Corporation
- Fresenius Kabi
- Haemonetics Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Terumo Corporation | ✓ | ◐ | ◐ | ✓ | ✓ | ◐ |
| Fresenius Kabi | ◐ | ✓ | ◐ | ◐ | ◐ | ✓ |
| Haemonetics Corporation | ✓ | ◐ | ✓ | ◐ | − | ◐ |
| Baxter International Inc. | ◐ | ✓ | ◐ | ✓ | ◐ | ✓ |
| Macopharma | ◐ | − | ◐ | ◐ | ◐ | − |
| Nipro Corporation | ◐ | ✓ | ◐ | − | ◐ | − |
| Sartorius AG | − | − | ◐ | − | − | − |
| Grifols | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Terumo Corporation83
2Fresenius Kabi77
3Haemonetics Corporation74
4Baxter International Inc.72
5Macopharma67
6Nipro Corporation60
7Sartorius AG48
8Grifols46
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Terumo Corporation
Challenger4
Strong scale, closing on the leaders.
Fresenius KabiHaemonetics CorporationBaxter International Inc.Macopharma
Contender1
Focused players with pockets of strength.
Nipro Corporation
Niche2
Specialists in a single segment or region.
Sartorius AGGrifols
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Filter Type in North America, then scale across Whole Blood Transfusion Filters Market — a $180M beachhead inside a $3.30B market.
Beachhead (SOM)$180Mobtainable near-term
Serviceable (SAM)$1.13Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Leukocyte Reduction Filters
Best fit — highest urgency & budget in Filter Type.
Economic buyer79 fit
Microaggregate Filters
Strong fit — clear ROI and a fast path to value.
End user70 fit
Blood Transfusion Set Filters
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Filter Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel29%
Digital / self-serve18%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Filter Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Whole Blood Transfusion Filters Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified22%
Evaluation13%
Closed-won5%
$9.5KCAC
$43KLTV
4.6:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Whole Blood Transfusion Filters Market is a high-growth opportunity — $1.15B by 2033, compounding at 10.4%.
TAM · 2025$522Mtoday
TAM · 2033$1.15Bforecast
CAGR10.4%2027–2033
Cumulative$7.21Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.15BTotal addressable market
SAM$418MServiceable available market
SOM$68MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.4% CAGR
Demand compounds through 2033, outpacing GDP across Filter Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Filter Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.15BLarge & growingTAM by 2033 at 10.4% CAGR
$418MServiceable nowreachable with today’s model
$68MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$897MBear6.7% CAGR
$1.15BBase10.4% CAGR
$1.47BBull13.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Whole Blood Transfusion Filters Market — a $10.2B market by 2033. Plan: grow share from 9.0% to 15.4%.
Market size · 2033$10.2Btotal addressable
Market CAGR10.5%2027–2033
Target share15.4%from 9.0% today
Revenue ambition$1.58Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.0% | 15.4% | At risk |
| Revenue | $940M | $1.58B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 37.1% | 38.1% | Behind |
| Customer retention | 85.0% | 95.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Filter Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Filter Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $180M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Filter Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Whole Blood Transfusion Filters Market conversation — a $1.56B market you can size, segment and defend in minutes.
Market size · 2033$1.56Btotal opportunity
Growth7.7%CAGR to 2033
Addressable buyers1,615+accounts in scope
Typical ROI5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Filter Type
Goal Grow share in Filter Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5×return on cost, year one
< 3 mopayback period
$43K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Terumo CorporationFresenius KabiHaemonetics CorporationBaxter International Inc.MacopharmaNipro CorporationSartorius AGGrifols+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Whole Blood Transfusion Filters Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Whole Blood Transfusion Filters Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Whole Blood Polymorphonuclear Cell Isolation Kit Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportWhole Blood, Plasma and Serum Viscometers Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportWhole Blood Coagulometers Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportWhole Blood Coagulation Testing Equipment Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportWhole Blood Coagulation Analyzers (WBCAs) Market
Market size, share, segmentation and regional forecast.
$688M market · 2025 base year
View reportWhole Blood Coagulation Analyzer Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportWhole Blood Blood Gas Analyzer Market
Market size, share, segmentation and regional forecast.
$344M market · 2025 base year
View reportWhitestrips Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportWhite Petroleum Jelly Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportWhiten Porcelain Veneer Market
Market size, share, segmentation and regional forecast.
$302M market · 2025 base year
View reportWhite Matter Injury Treatment Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportWhite Light Rigid Endoscope Market
Market size, share, segmentation and regional forecast.
$847M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.